Drawing for PALDRONABOL

USPTO serial 97724128

PALDRONABOL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BECKER, JOSEPH RAPHAEL
Law office
LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PALDRONABOL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael G Shariff

MICHAEL G SHARIFF INVENTA CAPITAL PLC40900 WOODWARD AVENUE, SUITE 111BLOOMFIELD HILLS, MI 48304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Drug discovery services for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Pharmaceutical research services; Research on the subject of pharmaceuticals for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Technical research in the field of pharmaceutical studies; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics for alleviating the symptoms of Parkinsonism/ Parkinson's disease ; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Development of pharmaceutical preparations and medicines for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Development of pharmaceutical preparations, used internally as pills and other solids, and also used as sprays and liquids, for killing viruses, bacteria, coronaviruses including COVID-19, biofilms, fungi, mold, and spores, and for the treatment and prevention of diabetes; Pharmaceutical product evaluation, scientific and technological services and research and design services relating thereto, namely, scientific research, research and design in the fields of pharmaceuticals, agrochemicals, bioactive compounds, fine chemicals, chemical feed stocks, polymers, paints, dyestuffs, adhesives, material sciences, engineering, nanomaterials, and foodstuffs; Chemical research; Chemical research, namely, chemical technological research; Chemical analysis; Chemistry services, namely, chemistry research, laboratory research in the field of chemistry; Chemistry consultation; Scientific research relating to chemistry for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Research and development services in the field of chemistry for alleviating the symptoms of Parkinsonism/ Parkinson's disease; Design and development of chemical compounds; Design and development of synthetic chemical compounds; Rental of laboratory apparatus and instruments for alleviating the symptoms of Parkinsonism/ Parkinson's diseaseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Sep 13, 2023MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 13, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 13, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
May 30, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 30, 2023DOCKASSIGNED TO EXAMINER—
Jan 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 22, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance